Ceredex Value Advisors LLC acquired a new position in Ventas, Inc. (NYSE:VTR – Free Report) during the second quarter, HoldingsChannel.com reports. The fund acquired 270,350 shares of the real estate investment trust’s stock, valued at approximately $24,007,000.
Several other institutional investors have also added to or reduced their stakes in VTR. NewEdge Advisors LLC increased its position in Ventas by 856.1% during the 1st quarter. NewEdge Advisors LLC now owns 7,926 shares of the real estate investment trust’s stock valued at $545,000 after purchasing an additional 7,097 shares during the period. Empowered Funds LLC lifted its position in shares of Ventas by 6.8% in the 1st quarter. Empowered Funds LLC now owns 8,373 shares of the real estate investment trust’s stock worth $576,000 after purchasing an additional 536 shares during the period. Woodline Partners LP boosted its stake in shares of Ventas by 46.8% in the 1st quarter. Woodline Partners LP now owns 36,826 shares of the real estate investment trust’s stock valued at $2,532,000 after purchasing an additional 11,739 shares during the last quarter. Focus Partners Wealth boosted its stake in shares of Ventas by 130.4% in the 1st quarter. Focus Partners Wealth now owns 21,613 shares of the real estate investment trust’s stock valued at $1,486,000 after purchasing an additional 12,233 shares during the last quarter. Finally, Gamco Investors INC. ET AL acquired a new stake in shares of Ventas during the second quarter worth $805,000. 94.18% of the stock is currently owned by institutional investors.
Ventas Trading Up 1.1%
VTR opened at $92.82 on Friday. Ventas, Inc. has a fifty-two week low of $66.38 and a fifty-two week high of $101.60. The firm has a market capitalization of $47.61 billion, a PE ratio of 171.89, a P/E/G ratio of 2.12 and a beta of 0.69. The company has a debt-to-equity ratio of 0.86, a current ratio of 0.44 and a quick ratio of 0.44. The company’s 50-day moving average is $91.18 and its 200 day moving average is $87.04.
Insider Buying and Selling at Ventas
In related news, Director Michael J. Embler bought 2,500 shares of the business’s stock in a transaction that occurred on Wednesday, June 3rd. The shares were bought at an average price of $78.81 per share, with a total value of $197,025.00. Following the completion of the transaction, the director directly owned 19,202 shares in the company, valued at approximately $1,513,309.62. This represents a 14.97% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.53% of the stock is owned by corporate insiders.
Wall Street Analysts Forecast Growth
Several equities analysts recently issued reports on VTR shares. Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a $100.00 target price on shares of Ventas in a report on Tuesday, June 16th. Mizuho increased their price target on Ventas from $98.00 to $104.00 and gave the stock an “outperform” rating in a report on Wednesday, July 22nd. Cantor Fitzgerald lifted their price objective on Ventas from $97.00 to $102.00 and gave the stock an “overweight” rating in a research report on Friday, July 31st. UBS Group boosted their price objective on Ventas from $85.00 to $93.00 and gave the company a “neutral” rating in a research note on Monday, May 4th. Finally, Royal Bank Of Canada upped their target price on Ventas from $98.00 to $99.00 and gave the company an “outperform” rating in a research report on Friday, August 14th. Fifteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $98.00.
About Ventas
Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas’ business model combines property ownership with active asset management and capital markets activity.
Read More
- Five stocks we like better than Ventas
- 3 Energy Stocks Raising Dividends as the Sector Surges
- 5 Reasons the S&P 500 Could Keep Rallying Through Year-End
- Walmart’s Post-Earnings Drop Could Be a Buying Opportunity
- The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future
Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR – Free Report).
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
